Treatment for Parkinson’s Disease (PD)
The primary purpose of this study is to see how safe and how well it is tolerated when the study drug is given in one injection dose, and the secondary purpose is to measure and compare levels of study drug (HNC364) and its biomarkers in your blood.
VOLUNTEERS MUST BE:
Ø Healthy male and female participants
Ø 18-45 years old
Ø Non-smokers
Ø Not currently taking any medication